Interleukin Antagonists: Have We Found the Right One to Block? Are Cardiovascular Effects of Biologic Therapies Similar?

Affiliations

¹ From the Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA.
² From the Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA. aquyyum@emory.edu.

Editorial

Ayman Samman Tahhan et al. Circ Cardiovasc Imaging. 2017 Sep.

. 2017 Sep;10(9):e006919.

doi: 10.1161/CIRCIMAGING.117.006919.

¹ From the Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA.
² From the Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA. aquyyum@emory.edu.

No abstract available

Keywords: Editorials; cytokines; imaging; interleukin; macrophages; myocarditis.

Comment on

Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis.
Ikonomidis I, Papadavid E, Makavos G, Andreadou I, Varoudi M, Gravanis K, Theodoropoulos K, Pavlidis G, Triantafyllidi H, Moutsatsou P, Panagiotou C, Parissis J, Iliodromitis E, Lekakis J, Rigopoulos D. Ikonomidis I, et al. Circ Cardiovasc Imaging. 2017 Sep;10(9):e006283. doi: 10.1161/CIRCIMAGING.117.006283. Circ Cardiovasc Imaging. 2017. PMID: 28899951 Clinical Trial.